Intoxicating hemp-derived cannabinoids (IHDC) – such as delta-8 THC, delta-10 THC, and hexahydrocannabinol (HHC) – have been major disruptors in the CBD and legal cannabis sectors in the US for some time now. A trend has recently emerged where states have decided to regulate IHDC sales instead of banning them, thereby acknowledging their legal status.
This report details and analyses recent developments in the regulation of IHDCs in the US.
“ US regulatory trends on intoxicating hemp-derived cannabinoids ”
Buy report request information:
“ US regulatory trends on intoxicating hemp-derived cannabinoids ”
We also invite you to enjoy our FREE TRIAL
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.